Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3610 entries
Sorted by: Best Match Show Resources per page
Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress

pipeline programs

Henderson V.
GSID: 2-37ZobCr74J
KS Watson, V Henderson, M Murray… - … in community health …, 2019 - ncbi.nlm.nih.gov

Background African American men (AAM) are underrepresented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low …

Cite
Watson, K. S., Henderson, V., Murray, M., Murphy, A. B., Levi, J. B., McDowell, T., ... & Winn, R. A. (2019). Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress. Progress in community health partnerships: research, education, and action, 13(5), 103.
Watson, Karriem S., et al. "Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress." Progress in community health partnerships: research, education, and action 13.5 (2019): 103.
Copy Download .nbib Format: MLA
Penile Metastases of Recurrent Prostatic Adenocarcinoma without PSA Level Increase: A Case Report.

Journal of clinical imaging science

Pierro A, Cilla S, Digesù C, Morganti AG.
PMID: 22919558
J Clin Imaging Sci. 2012;2:44. doi: 10.4103/2156-7514.99178. Epub 2012 Jul 28.

We report a case of penile metastases from recurrent prostatic adenocarcinoma that was the first sign of a widespread metastatic disease in the absence of any increase in prostate-specific antigen (PSA) level. In April 2011, an 80-year-old man presented...

Cite
Pierro A, Cilla S, Digesù C, et al. Penile Metastases of Recurrent Prostatic Adenocarcinoma without PSA Level Increase: A Case Report. J Clin Imaging Sci. 2012;2:44doi: 10.4103/2156-7514.99178.
Pierro, A., Cilla, S., Digesù, C., & Morganti, A. G. (2012). Penile Metastases of Recurrent Prostatic Adenocarcinoma without PSA Level Increase: A Case Report. Journal of clinical imaging science, 244. https://doi.org/10.4103/2156-7514.99178
Pierro, Antonio, et al. "Penile Metastases of Recurrent Prostatic Adenocarcinoma without PSA Level Increase: A Case Report." Journal of clinical imaging science vol. 2 (2012): 44. doi: https://doi.org/10.4103/2156-7514.99178
Pierro A, Cilla S, Digesù C, Morganti AG. Penile Metastases of Recurrent Prostatic Adenocarcinoma without PSA Level Increase: A Case Report. J Clin Imaging Sci. 2012;2:44. doi: 10.4103/2156-7514.99178. Epub 2012 Jul 28. PMID: 22919558; PMCID: PMC3424701.
Copy Download .nbib Format: NLM
Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience.

Urology annals

Dogra PN, Saini AK, Singh P, Bora G, Nayak B.
PMID: 24833824
Urol Ann. 2014 Apr;6(2):130-4. doi: 10.4103/0974-7796.130555.

OBJECTIVES: To report our initial experience and technique of performing robot-assisted laparoscopic radical prostatectomy (RALP) with the extraperitoneal approach.MATERIALS AND METHODS: Twenty-seven patients, between September 2010 to January 2012, were included in the study. All patients underwent extraperitoneal robot-assisted...

Cite
Dogra PN, Saini AK, Singh P, et al. Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience. Urol Ann. 2014;6(2):130-4doi: 10.4103/0974-7796.130555.
Dogra, P. N., Saini, A. K., Singh, P., Bora, G., & Nayak, B. (2014). Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience. Urology annals, 6(2), 130-4. https://doi.org/10.4103/0974-7796.130555
Dogra, Prem Nath, et al. "Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience." Urology annals vol. 6,2 (2014): 130-4. doi: https://doi.org/10.4103/0974-7796.130555
Dogra PN, Saini AK, Singh P, Bora G, Nayak B. Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience. Urol Ann. 2014 Apr;6(2):130-4. doi: 10.4103/0974-7796.130555. PMID: 24833824; PMCID: PMC4021652.
Copy Download .nbib Format: NLM
Abdominal Mass After Robotic Assisted Laparoscopic Prostatectomy: Spigelian Type Trocar Hernia.

Current urology

Jazayeri SB, Tsui JF, Samadi DB.
PMID: 28878603
Curr Urol. 2017 Aug;10(3):163-165. doi: 10.1159/000447174. Epub 2017 Jul 30.

Prostate cancer is the most common cancer in men. Men are diagnosed at early stages of prostate cancer with the use of prostate specific antigen. Surgical removal of the prostate is the standard treatment in localized prostate cancer. Complications...

Cite
Jazayeri SB, Tsui JF, Samadi DB. Abdominal Mass After Robotic Assisted Laparoscopic Prostatectomy: Spigelian Type Trocar Hernia. Curr Urol. 2017;10(3):163-165doi: 10.1159/000447174.
Jazayeri, S. B., Tsui, J. F., & Samadi, D. B. (2017). Abdominal Mass After Robotic Assisted Laparoscopic Prostatectomy: Spigelian Type Trocar Hernia. Current urology, 10(3), 163-165. https://doi.org/10.1159/000447174
Jazayeri, Seyed Behzad, et al. "Abdominal Mass After Robotic Assisted Laparoscopic Prostatectomy: Spigelian Type Trocar Hernia." Current urology vol. 10,3 (2017): 163-165. doi: https://doi.org/10.1159/000447174
Jazayeri SB, Tsui JF, Samadi DB. Abdominal Mass After Robotic Assisted Laparoscopic Prostatectomy: Spigelian Type Trocar Hernia. Curr Urol. 2017 Aug;10(3):163-165. doi: 10.1159/000447174. Epub 2017 Jul 30. PMID: 28878603; PMCID: PMC5582531.
Copy Download .nbib Format: NLM
Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials.

Oncotarget

Kang M, Jeong CW, Kwak C, Ku JH, Kim HH.
PMID: 28938672
Oncotarget. 2017 May 10;8(35):59690-59697. doi: 10.18632/oncotarget.17741. eCollection 2017 Aug 29.

Various novel androgen receptor (AR) targeting drugs have been developed recently and have shown beneficial effects on survival in patients with metastatic castration-resistant prostate cancer (mCRPC). However, no consensus has been reached regarding which of these agents provides the...

Cite
Kang M, Jeong CW, Kwak C, et al. Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials. Oncotarget. 2017;8(35):59690-59697doi: 10.18632/oncotarget.17741.
Kang, M., Jeong, C. W., Kwak, C., Ku, J. H., & Kim, H. H. (2017). Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials. Oncotarget, 8(35), 59690-59697. https://doi.org/10.18632/oncotarget.17741
Kang, Minyong, et al. "Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials." Oncotarget vol. 8,35 (2017): 59690-59697. doi: https://doi.org/10.18632/oncotarget.17741
Kang M, Jeong CW, Kwak C, Ku JH, Kim HH. Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials. Oncotarget. 2017 May 10;8(35):59690-59697. doi: 10.18632/oncotarget.17741. eCollection 2017 Aug 29. PMID: 28938672; PMCID: PMC5601768.
Copy Download .nbib Format: NLM
Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy.

Journal of robotic surgery

Bove AM, Altobelli E, Sergi F, Buscarini M.
PMID: 27637245
J Robot Surg. 2014 Mar;8(1):85-8. doi: 10.1007/s11701-013-0392-5. Epub 2013 Jan 18.

INTRODUCTION: Robot-assisted laparoscopic radical prostatectomy (RALRP) is one of the best treatment for patients with localized prostate cancer. RALRP is currently performed in patients without previous surgical treatment for benign prostatic hyperplasia. This paper presents a successfully performed RALRP...

Cite
Bove AM, Altobelli E, Sergi F, et al. Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy. J Robot Surg. 2013;8(1):85-8doi: 10.1007/s11701-013-0392-5.
Bove, A. M., Altobelli, E., Sergi, F., & Buscarini, M. (2014). Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy. Journal of robotic surgery, 8(1), 85-8. https://doi.org/10.1007/s11701-013-0392-5
Bove, Alfredo Maria, et al. "Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy." Journal of robotic surgery vol. 8,1 (2014): 85-8. doi: https://doi.org/10.1007/s11701-013-0392-5
Bove AM, Altobelli E, Sergi F, Buscarini M. Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy. J Robot Surg. 2014 Mar;8(1):85-8. doi: 10.1007/s11701-013-0392-5. Epub 2013 Jan 18. PMID: 27637245.
Copy Download .nbib Format: NLM
Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients.

Oncoscience

Zharinov GM, Bogomolov OA, Neklasova NN, Anisimov VN.
PMID: 28484728
Oncoscience. 2017 Feb 24;4(1):7-13. doi: 10.18632/oncoscience.337. eCollection 2017 Jan.

Despite the prostate-specific antigen (PSA) serum level commonly uses as tumor marker in diagnosis of prostate cancer, it seems that PSA doubling time (PSADT) could be more useful indicator of tumor behavior and of prognosis for patients. The results...

Cite
Zharinov GM, Bogomolov OA, Neklasova NN, et al. Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients. Oncoscience. 2017;4(1):7-13doi: 10.18632/oncoscience.337.
Zharinov, G. M., Bogomolov, O. A., Neklasova, N. N., & Anisimov, V. N. (2017). Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients. Oncoscience, 4(1), 7-13. https://doi.org/10.18632/oncoscience.337
Zharinov, Gennady M, et al. "Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients." Oncoscience vol. 4,1 (2017): 7-13. doi: https://doi.org/10.18632/oncoscience.337
Zharinov GM, Bogomolov OA, Neklasova NN, Anisimov VN. Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients. Oncoscience. 2017 Feb 24;4(1):7-13. doi: 10.18632/oncoscience.337. eCollection 2017 Jan. PMID: 28484728; PMCID: PMC5361642.
Copy Download .nbib Format: NLM
Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin.

CPT: pharmacometrics & systems pharmacology

van Hasselt JG, Gupta A, Hussein Z, Beijnen JH, Schellens JH, Huitema AD.
PMID: 26312162
CPT Pharmacometrics Syst Pharmacol. 2015 Jul;4(7):386-95. doi: 10.1002/psp4.49. Epub 2015 Jun 30.

Frameworks that associate cancer dynamic disease progression models with parametric survival models for clinical outcome have recently been proposed to support decision making in early clinical development. Here we developed such a disease progression clinical outcome model for castration-resistant...

Cite
van Hasselt JG, Gupta A, Hussein Z, et al. Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin. CPT Pharmacometrics Syst Pharmacol. 2015;4(7):386-95doi: 10.1002/psp4.49.
van Hasselt, J. G., Gupta, A., Hussein, Z., Beijnen, J. H., Schellens, J. H., & Huitema, A. D. (2015). Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin. CPT: pharmacometrics & systems pharmacology, 4(7), 386-95. https://doi.org/10.1002/psp4.49
van Hasselt, J G C, et al. "Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin." CPT: pharmacometrics & systems pharmacology vol. 4,7 (2015): 386-95. doi: https://doi.org/10.1002/psp4.49
van Hasselt JG, Gupta A, Hussein Z, Beijnen JH, Schellens JH, Huitema AD. Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin. CPT Pharmacometrics Syst Pharmacol. 2015 Jul;4(7):386-95. doi: 10.1002/psp4.49. Epub 2015 Jun 30. PMID: 26312162; PMCID: PMC4544052.
Copy Download .nbib Format: NLM
Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis.

Journal of robotic surgery

Cheetham PJ, Lee DJ, Rose-Morris A, Brewster SF, Badani KK.
PMID: 27638755
J Robot Surg. 2010 Sep;4(3):155-60. doi: 10.1007/s11701-010-0200-4. Epub 2010 Jul 10.

We report on differences in patient demographics in those men choosing to undergo radical prostatectomy in a UK center where there is no influence of robotic surgery and in those choosing radical prostatectomy in a US center where there...

Cite
Cheetham PJ, Lee DJ, Rose-Morris A, et al. Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis. J Robot Surg. 2010;4(3):155-60doi: 10.1007/s11701-010-0200-4.
Cheetham, P. J., Lee, D. J., Rose-Morris, A., Brewster, S. F., & Badani, K. K. (2010). Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis. Journal of robotic surgery, 4(3), 155-60. https://doi.org/10.1007/s11701-010-0200-4
Cheetham, Philippa J, et al. "Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis." Journal of robotic surgery vol. 4,3 (2010): 155-60. doi: https://doi.org/10.1007/s11701-010-0200-4
Cheetham PJ, Lee DJ, Rose-Morris A, Brewster SF, Badani KK. Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis. J Robot Surg. 2010 Sep;4(3):155-60. doi: 10.1007/s11701-010-0200-4. Epub 2010 Jul 10. PMID: 27638755.
Copy Download .nbib Format: NLM
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.

Clinical genitourinary cancer

Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.
PMID: 28864223
Clin Genitourin Cancer. 2017 Aug 03; doi: 10.1016/j.clgc.2017.07.026. Epub 2017 Aug 03.

BACKGROUND: Salvage radiotherapy (SRT) has been successfully used for recurrent prostate cancer after radical prostatectomy; however, the optimal timing of SRT remains controversial. Our objective was to identify the risk factors for disease progression after SRT, with a focus...

Cite
Rodin D, Drumm M, Clayman R, et al. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clin Genitourin Cancer. 2017;doi: 10.1016/j.clgc.2017.07.026.
Rodin, D., Drumm, M., Clayman, R., Buscariollo, D. L., Galland-Girodet, S., Eidelman, A., Feldman, A. S., Dahl, D. M., McGovern, F. J., Olumi, A. F., Niemierko, A., Shipley, W. U., Zietman, A. L., & Efstathiou, J. A. (2017). Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clinical genitourinary cancer, . https://doi.org/10.1016/j.clgc.2017.07.026
Rodin, Danielle, et al. "Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience." Clinical genitourinary cancer vol. (2017). doi: https://doi.org/10.1016/j.clgc.2017.07.026
Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clin Genitourin Cancer. 2017 Aug 03; doi: 10.1016/j.clgc.2017.07.026. Epub 2017 Aug 03. PMID: 28864223.
Copy Download .nbib Format: NLM
Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens.

Oncology letters

Glover M, Soni S, Ren Q, Maclennan GT, Fu P, Gupta S.
PMID: 28943900
Oncol Lett. 2017 Oct;14(4):3927-3934. doi: 10.3892/ol.2017.6668. Epub 2017 Jul 26.

The association between inflammation and cancer has been established in certain forms of human malignancies; however, its role in prostate cancer remains unclear. The present study investigates a possible association between chronic inflammation and the development of epithelial neoplasia...

Cite
Glover M, Soni S, Ren Q, et al. Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncol Lett. 2017;14(4):3927-3934doi: 10.3892/ol.2017.6668.
Glover, M., Soni, S., Ren, Q., Maclennan, G. T., Fu, P., & Gupta, S. (2017). Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncology letters, 14(4), 3927-3934. https://doi.org/10.3892/ol.2017.6668
Glover, Michael, et al. "Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens." Oncology letters vol. 14,4 (2017): 3927-3934. doi: https://doi.org/10.3892/ol.2017.6668
Glover M, Soni S, Ren Q, Maclennan GT, Fu P, Gupta S. Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncol Lett. 2017 Oct;14(4):3927-3934. doi: 10.3892/ol.2017.6668. Epub 2017 Jul 26. PMID: 28943900; PMCID: PMC5604163.
Copy Download .nbib Format: NLM
Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy.

Journal of robotic surgery

Kowalczyk KJ, Huang AC, Williams SB, Yu HY, Hu JC.
PMID: 27000927
J Robot Surg. 2013 Sep;7(3):301-4. doi: 10.1007/s11701-012-0377-9. Epub 2012 Aug 19.

Robotic-assisted laparoscopic prostatectomy (RALP) has surged in popularity since US Food and Drug Administration approval in 2000. Advantages include improved visualization and increased instrument dexterity within the pelvis. Obesity and narrow pelves have been associated with increased difficulty during...

Cite
Kowalczyk KJ, Huang AC, Williams SB, et al. Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy. J Robot Surg. 2012;7(3):301-4doi: 10.1007/s11701-012-0377-9.
Kowalczyk, K. J., Huang, A. C., Williams, S. B., Yu, H. Y., & Hu, J. C. (2013). Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy. Journal of robotic surgery, 7(3), 301-4. https://doi.org/10.1007/s11701-012-0377-9
Kowalczyk, Keith J, et al. "Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy." Journal of robotic surgery vol. 7,3 (2013): 301-4. doi: https://doi.org/10.1007/s11701-012-0377-9
Kowalczyk KJ, Huang AC, Williams SB, Yu HY, Hu JC. Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy. J Robot Surg. 2013 Sep;7(3):301-4. doi: 10.1007/s11701-012-0377-9. Epub 2012 Aug 19. PMID: 27000927.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3610 entries